Colorectal Cancer Clinical Trials in Miami

Showing 141-142 of 142 trials

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

NCT00625573

This is an open-label, phase II study to evaluate the efficacy and safety of Abraxane in combination with Capecitabine in patients with metastatic colorectal cancer in the second or third line

Colorectal Cancer

Mt. Sinai Medical Center, Miami29 participantsStarted Sep 2007

Miami Beach, Florida, United States

COMPLETED440 miles

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NCT00410579

RATIONALE: Learning about quality of life, symptoms, and health behaviors in colorectal cancer survivors may help to determine the long-term effects of colon and rectal cancer treatments and may help to improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is looking at patient-reported outcomes in long-term survivors of colon and rectal cancers.

Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more

NSABP Foundation Inc744 participantsStarted Nov 2006

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +197 more locations

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Colorectal Cancer Trials in Other Cities

Other Conditions in Miami